The effect of rilonacept versus placebo on health-related quality of life in patients with poorly controlled familial Mediterranean fever

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Hashkes, Philip J ^a,b   Spalding, Steven J ^a   Hajj Ali, Rula ^a   Giannini, Edward H ^c   Johnson, Anne ^c   Barron, Karyl S ^d   Weisman, Michael H ^e   Pashinian, Noune ^e   Reiff, Andreas O ^f   Samuels, Jonathan ^g   Wright, Dowain ^h   Lovell, Daniel J ^c   Huang, Bin ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

^g NYU HOSPITAL FOR JOINT DISEASES   (United States)

^h CHILDREN S HOSPITAL CENTRAL CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE; FIBRINOGEN; RILONACEPT; SERUM AMYLOID A; HYBRID PROTEIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; ERYTHROCYTE SEDIMENTATION RATE; ETHNICITY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FEVER; HUMAN; MALE; MENTAL HEALTH; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF ESTEEM; SHORT FORM 36; THORAX PAIN; CLINICAL TRIAL; COMPARATIVE STUDY; QUESTIONNAIRE; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; DOUBLE-BLIND METHOD; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901811336     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/854842     Document Type: Article

References (30)

1. Sohar E., Gafni J., Pras M., Heller H., Familial Mediterranean fever. A survey of 470 cases and review of the literature. The American Journal of Medicine 1967 43 2 227 253 2-s2.0-0014118417
2. The International FMF Consortium, Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997 90 797 807
3. The French FMF Consortium, A candidate gene for familial Mediterranean fever. Nature Genetics 1997 17 25 31
4. Ben-Chetrit E., Touitou I., Familial Mediterranean fever in the world. Arthritis Care and Research 2009 61 10 1447 1453 2-s2.0-70349774428 10.1002/art.24458
5. Goldfinger S. E., Colchicine for familial Mediterranean fever. The New England Journal of Medicine 1972 287 25 1302 2-s2.0-0015519154
6. Zemer D., Revach M., Pras M., A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. The New England Journal of Medicine 1974 291 18 932 934 2-s2.0-0016223474
7. Dinarello C. A., Wolff S. M., Goldfinger S. E., Dale D. C., Alling D. W., Colchicine therapy for familial Mediterranean fever. A double blind trial. The New England Journal of Medicine 1974 291 18 934 937 2-s2.0-0016251282
8. Zemer D., Pras M., Sohar E., Modan M., Cabili S., Gafni J., Colchicine in the prevention and treatment of amyloidosis of familial Mediterranean fever. The New England Journal of Medicine 1986 314 16 1001 1005 2-s2.0-0022570984 (Pubitemid 16138694)
9. Lidar M., Scherrmann J. M., Shinar Y., Chetrit A., Niel E., Gershoni-Baruch R., Langevitz P., Livneh A., Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Seminars in Arthritis and Rheumatism 2004 33 4 273 282 2-s2.0-1442274819 10.1053/S0049-0172(03)00137-9 (Pubitemid 38280826)
10. Ben-Chetrit E., Ozdogan H., Non-response to colchicine in FMF-definition, causes and suggested solutions. Clinical and Experimental Rheumatology 2008 26 supplement 50 S49 S51 2-s2.0-55049131412
11. Buskila D., Zaks N., Neumann L., Quality of life of patients with familial Mediterranean fever. Clinical and Experimental Rheumatology 1997 15 355 360 (Pubitemid 27323995)
12. Press J., Neumann L., Abu-Shakra M., Bolotin A., Buskila D., Living with a child with familial Mediterranean fever: does it affect the quality of life of the parents? Clinical and Experimental Rheumatology 2000 18 1 103 106 2-s2.0-0033956328 (Pubitemid 30102055)
13. Makay B., Ünsal E., Arslan N., Varni J. W., Health-related quality of life of school-age children with familial Mediterranean fever. Clinical and Experimental Rheumatology 2009 27 supplement 53 S96 S101 2-s2.0-70350135777
14. Deger S. M., Ozturk M. A., Demirag M. D., Aslan S., Goker B., Haznedaroglu S., Onat A. M., Health-related quality of life and its associations with mood condition in familial Mediterranean fever patients. Rheumatology International 2011 31 5 623 628 2-s2.0-79955718346 10.1007/s00296-009-1334-4
15. Sahin S., Yalcin I., Senel S., Assessment life quality of familial Mediterranean fever patients by short form-36 and its relationship with disease parameters. European Review for Medical and Pharmacological Sciences 2013 17 958 963
16. Giese A., Kurucay M., Kilic L., Quality of life in adult patients with familial Mediterranean fever living in Germany or Turkey compared to healthy subjects: a study evaluating the effect of disease severity and country of residence. Rheumatology International 2013 33 1713 1719
17. Alayli G., Durmus D., Ozkaya O., Sen H. E., Genc G., Kuru O., Frequency of juvenile fibromyalgia syndrome in children with familial Mediterranean fever: effects on depression and quality of life. Clinical and Experimental Rheumatology 2011 29 supplement 69 S127 S132 2-s2.0-84858801340
18. Langevitz P., Buskila D., Finkelstein R., Zaks N., Neuman L., Sukenik S., Smythe H. A., Pras M., Fibromyalgia in familial Mediterranean fever. Journal of Rheumatology 1994 21 7 1335 1337 2-s2.0-0028074265 (Pubitemid 24234676)
19. Kasapçopur Ö., Tengirsek M., Ercan G., Yologlu N., Caliskan S., Sever L., Arisoy N., Hypermobility and fibromyalgia frequency in childhood familial Mediterranean fever. Clinical and Experimental Rheumatology 2004 22 supplement 34 S79 2-s2.0-16544364140 (Pubitemid 39386913)
20. Arcalyst, [Rilonacept] Prescribing Information 2009 Tarrytown, NY, USA Regeneron Pharmaceuticals, Inc.
21. Hashkes P. J., Spalding S. J., Giannini E. H., Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Annals of Internal Medicine 2012 157 533 541
22. Landgraf J. M., Abetz L., Ware J. E., The CHQ User's Manual 1996 Boston, Mass, USA The Health Institute, New England Medical Center
23. Ruperto N., Ravelli A., Pistorio A., Malattia C., Cavuto S., Gado-West L., Tortorelli A., Landgraf J. M., Singh G., Martini A., Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clinical and Experimental Rheumatology 2001 19 4 S1 S9 2-s2.0-4143078383 (Pubitemid 33730178)
24. Amaryan G., Astvatsatryan V., Gabrielyan E., Panossian A., Panosyan V., Wikman G., Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard-a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with familial Mediterranean fever. Phytomedicine 2003 10 4 271 285 2-s2.0-0038249043 10.1078/094471103322004767 (Pubitemid 36597163)
25. Kone-Paut I., Lachmann H. J., Kuemmerle-Deschner J. B., Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study. Arthritis Research & Therapy 2011 13 R202
26. Ozçakar Z. B., Yalçinkaya F., Yuksel S., Acar B., Gokmen D., Ekim M., Possible effect of subclinical inflammation on daily life in familial Mediterranean fever. Clinical Rheumatology 2006 25 149 152 (Pubitemid 43372309)
27. Yenokyan G., Armenian H. K., Triggers for attacks in familial Mediterranean fever: application of the case-crossover design. American Journal of Epidemiology 2012 175 1054 1061
28. Gidron Y., Berkovitch M., Press J., Psychosocial correlates of incidence of attacks in children with familial Mediterranean fever. Journal of Behavioral Medicine 2003 26 2 95 104 2-s2.0-0038033157 10.1023/A:1023038504481 (Pubitemid 36528184)
29. Onat A. M., Öztürk M. A., Özçakar L., Üreten K., Kaymak S. U., Kiraz S., Ertenli I., Çalgüneri M., Selective serotonin reuptake inhibitors reduce the attack frequency in familial Mediterranean fever. Tohoku Journal of Experimental Medicine 2007 211 1 9 14 2-s2.0-33846117487 10.1620/tjem.211.9 (Pubitemid 46062215)
30. Lepore L., Paloni G., Caorsi R., Alessio M., Rigante D., Ruperto N., Cattalini M., Tommasini A., Zulian F., Ventura A., Martini A., Gattorno M., Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with anakinra. Journal of Pediatrics 2010 157 2 310 315 2-s2.0-77955291693 10.1016/j.jpeds.2010.02.040